D008545DisordersC04.557.465.625.650.510C04.557.580.625.650.510C04.557.665.510501370.879317Melanomaprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDermatologyPathologyWake Forest School of MedicineEdwardLevineEdward A. Levine MD36.08959100000000-80.26859900000000273Levine, EdwardProfessorMichaelChanMichael D. Chan MD36.09103700000000-80.26909600000000614Chan, MichaelAssistant ProfessorStevenFeldmanSteven R. Feldman MD, PhD36.08959100000000-80.26859900000000884Feldman, StevenProfessor31371315Binkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh AThe British journal of ophthalmologyBinkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh A. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes. Br J Ophthalmol. 2020 04; 104(4):524-528.Br J Ophthalmol2019-08-01T00:00:002019A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.31126364Brooks WC, Votanopoulos KI, Russell GB, Shen P, Levine EAThe American surgeonBrooks WC, Votanopoulos KI, Russell GB, Shen P, Levine EA. Evaluation of Chest Radiographs and Laboratory Testing during Melanoma Staging Procedures. Am Surg. 2019 May 01; 85(5):505-510.Am Surg2019-05-01T00:00:002019Evaluation of Chest Radiographs and Laboratory Testing during Melanoma Staging Procedures.Internal Medicine, Hematology & OncologyPhysiology & PharmacologySurgery, Oncology35284940Triozzi PL, Stirling ER, Song Q, Westwood B, Kooshki M, Forbes ME, Holbrook BC, Cook KL, Alexander-Miller MA, Miller LD, Zhang W, Soto-Pantoja DRClinical cancer research : an official journal of the American Association for Cancer ResearchTriozzi PL, Stirling ER, Song Q, Westwood B, Kooshki M, Forbes ME, Holbrook BC, Cook KL, Alexander-Miller MA, Miller LD, Zhang W, Soto-Pantoja DR. Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade. Clin Cancer Res. 2022 03 15; 28(6):1192-1202.Clin Cancer Res2022-03-15T00:00:002022Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade.35148834Wolff DW, Deng Z, Bianchi-Smiraglia A, Foley CE, Han Z, Wang X, Shen S, Rosenberg MM, Moparthy S, Yun DH, Chen J, Baker BK, Roll MV, Magiera AJ, Li J, Hurley E, Feltri ML, Cox AO, Lee J, Furdui CM, Liu L, Bshara W, LaConte LEW, Kandel ES, Pasquale EB, Qu J, Hedstrom L, Nikiforov MACell chemical biologyWolff DW, Deng Z, Bianchi-Smiraglia A, Foley CE, Han Z, Wang X, Shen S, Rosenberg MM, Moparthy S, Yun DH, Chen J, Baker BK, Roll MV, Magiera AJ, Li J, Hurley E, Feltri ML, Cox AO, Lee J, Furdui CM, Liu L, Bshara W, LaConte LEW, Kandel ES, Pasquale EB, Qu J, Hedstrom L, Nikiforov MA. Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4. Cell Chem Biol. 2022 Jun 16; 29(6):970-984.e6.Cell Chem Biol2022-02-10T00:00:002022Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4.HaodongXuHaodong Xu MD, PhD3737Xu, HaodongProfessor36039850Gross S, Hooper R, Tomar D, Armstead AP, Shanas N, Mallu P, Joshi H, Ray S, Chong PL, Astsaturov I, Farma JM, Cai KQ, Chitrala KN, Elrod JW, Zaidi MR, Soboloff JThe EMBO journalGross S, Hooper R, Tomar D, Armstead AP, Shanas N, Mallu P, Joshi H, Ray S, Chong PL, Astsaturov I, Farma JM, Cai KQ, Chitrala KN, Elrod JW, Zaidi MR, Soboloff J. Suppression of Ca2+ signaling enhances melanoma progression. EMBO J. 2022 Oct 04; 41(19):e110046.EMBO J2022-08-30T00:00:002022Suppression of Ca2+ signaling enhances melanoma progression.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorPierreTriozziPierre L. Triozzi MD36.09103700000000-80.269096000000001638Triozzi, PierreProfessor7.625210.011828750research area of0.9012290.0538087145subject area for